The latest announcement is out from Percheron Therapeutics ( (AU:PER) ).
Percheron Therapeutics Limited has announced a change in the substantial holding of its shares. Gregory Norman Peters, along with other associated individuals, has acquired a 5.1% voting power in the company. This development could impact the company’s governance and decision-making processes, reflecting a shift in shareholder influence. Stakeholders should monitor how this change in substantial holding might affect Percheron Therapeutics’ strategic direction and market positioning.
More about Percheron Therapeutics
YTD Price Performance: 0%
Average Trading Volume: 4,495
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $6.09M
Find detailed analytics on PER stock on TipRanks’ Stock Analysis page.